199105-17-4 Usage
Description
2-(4-Benzyl-piperazin-1-yl)aniline is a chemical compound belonging to the piperazine class, characterized by the molecular formula C18H22N2. It features a benzyl-piperazine group and an aniline group, which contribute to its potent and versatile nature as a building block in the synthesis of pharmaceutical drugs. 2-(4-Benzyl-piperazin-1-yl)aniline is particularly valuable in drug discovery and development due to its unique chemical structure and properties.
Uses
Used in Pharmaceutical Industry:
2-(4-Benzyl-piperazin-1-yl)aniline is used as a key intermediate in the synthesis of various pharmaceutical drugs for its ability to contribute to the development of central nervous system stimulants and antidepressants. Its presence in drug molecules can enhance their therapeutic effects and target specific biological pathways.
Used in Drug Discovery and Development:
As a versatile building block, 2-(4-Benzyl-piperazin-1-yl)aniline is utilized in drug discovery and development to create new biologically active compounds. Its chemical structure allows for the design of innovative drugs with potential applications in treating a range of medical conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 199105-17-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,9,1,0 and 5 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 199105-17:
(8*1)+(7*9)+(6*9)+(5*1)+(4*0)+(3*5)+(2*1)+(1*7)=154
154 % 10 = 4
So 199105-17-4 is a valid CAS Registry Number.
InChI:InChI=1/C17H21N3/c18-16-8-4-5-9-17(16)20-12-10-19(11-13-20)14-15-6-2-1-3-7-15/h1-9H,10-14,18H2
199105-17-4Relevant articles and documents
PROCESS AND NOVEL POLYMORPHIC FORM OF VORTIOXETINE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS
-
, (2019/01/15)
Processes are disclosed for making vortioxetine and pharmaceutically acceptable salts thereof. A propylene glycol solvate of vortioxetine hydrobromide is disclosed. A novel crystalline form of vortioxetine hydrobromide propylene glycol solvate, designated form AC1, is disclosed along with a method for making same. Form AC1 may be characterized by an x-ray powder diffraction pattern with peaks at about 19.64, 22.85, 25.51, 29.57, 30.18±0.2 degrees 2-theta.
Serine derived NK1 antagonists 2: A pharmacophore model for arylsulfonamide binding
Elliott,Broughton,Cascieri,Chicchi,Huscroft,Kurtz,MacLeod,Sadowski,Stevenson
, p. 1851 - 1856 (2007/10/03)
Modifications to the spirocyclic aryl sulfonamide portion of serine derived NK1 antagonists allow a partial pharmacophore model to be developed.
